Tatjana is a PhD Candidate at the Department of Pharmaceutical Biosciences, University of Oslo,
Norway. She is interested in how different drugs and substances affect our body, i.e. pharmacology.
She studies proteolytic enzymes with a particular focus on cysteine proteases (legumain, cathepsins)
and what roles these enzymes have in normal physiology and in diseases such as cancer,
atherosclerosis and osteoporosis. Currently, her main goal is to illuminate the cellular and molecular
mechanisms of legumain and cysteine cathepsins in bone remodeling and bone cell functions under
physiological and pathological conditions of bone loss and to utilize them as potential
pharmacological target molecules.